Adherence to Antiretroviral Therapy and Factors Affecting Low Medication Adherence Among Incident HIV-infected Individuals During 2009-2016: A Nationwide Study

Overview

Journal Sci Rep

Specialty Science

Date 2018 Feb 18

PMID 29453393

Citations 57

Authors

Jungmee Kim

Eunyoung Lee

Byung-Joo Park

Ji Hwan Bang

Jin Yong Lee

Affiliations

Soon will be listed here.

Abstract

For ideal clinical benefit, human immunodeficiency virus (HIV)-infected individuals should receive continuous medication. This is the first nationwide antiretroviral therapy (ART) adherence study in Asia, where medication monitoring at national level is systemically available. We estimated the ART adherence of incident HIV-infected individuals and investigated factors affecting low medication adherence using the national health insurance (NHI) claims data from 2007 to 2016. Medication possession ratio (MPR) was used to measure medication adherence and risk factors were identified by multivariable logistic regression analysis. Of the 8,501 newly diagnosed HIV-infected individuals during 2009-2016 with at least one ART prescription, 70.4% of HIV patients had adequate adherence to ART defined as MPR ≥95%. Requiring prophylactic antibiotics, female gender, age of 0-19 and same or over 50 s compared to 30-39, and having a history of malignancy, lower socioeconomic status, not visiting tertiary hospital, and being diagnosed in the earlier years were risk factors for lower adherence (Odds ratio 1.7, 1.6, 1.6, 1.4, 1.6, 2.1, 1.2, and 1.6 to 3.8 respectively). Health authority should take into consideration of these modifiable and unmodifiable barriers to establish sustainable monitoring system at national level and to improve adherence.

Citing Articles

HIV vaccination: Navigating the path to a transformative breakthrough-A review of current evidence.

Scott G, Worku D Health Sci Rep. 2024; 7(9):e70089.

PMID: 39319247 PMC: 11420300. DOI: 10.1002/hsr2.70089.

Comparing pill counts and patient self-reports versus DBS tenofovir concentrations as ART adherence measurements with virologic outcomes and HIV drug resistance in a cohort of adolescents and young adults failing ART in Harare, Zimbabwe.

Mtisi T, Kouamou V, Morse G, Dzinamarira T, Ndhlovu C J Infect Public Health. 2024; 17(9):102500.

PMID: 39173560 PMC: 11393767. DOI: 10.1016/j.jiph.2024.102500.

Antiretroviral Therapy Use and Disparities Among Medicare Beneficiaries with HIV.

Figueroa J, Duggan C, Phelan J, Ang L, Ebem F, Chu J J Gen Intern Med. 2024; 39(12):2196-2205.

PMID: 38865008 PMC: 11347507. DOI: 10.1007/s11606-024-08847-y.

The Uncontrollable Mortality Risk Hypothesis: Theoretical foundations and implications for public health.

Brown R, Pepper G Evol Med Public Health. 2024; 12(1):86-96.

PMID: 38807860 PMC: 11132133. DOI: 10.1093/emph/eoae009.

Factors associated with health-related quality of life among people living with HIV in South Korea: Tobit regression analysis.

Kim G, Kim L, Lee S, Shim M, Lee Y, Baek S PLoS One. 2024; 19(5):e0303568.

PMID: 38753733 PMC: 11098325. DOI: 10.1371/journal.pone.0303568.

References

S Ingersoll K, Heckman C . Patient-clinician relationships and treatment system effects on HIV medication adherence. AIDS Behav. 2005; 9(1):89-101. PMC: 2868061. DOI: 10.1007/s10461-005-1684-1. View

Schneider E, Whitmore S, Glynn K, Dominguez K, Mitsch A, McKenna M . Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged <18 months and for HIV infection and AIDS among children aged 18 months to <13 years--United States, 2008. MMWR Recomm Rep. 2008; 57(RR-10):1-12. View

Tapp C, Milloy M, Kerr T, Zhang R, Guillemi S, Hogg R . Female gender predicts lower access and adherence to antiretroviral therapy in a setting of free healthcare. BMC Infect Dis. 2011; 11:86. PMC: 3080305. DOI: 10.1186/1471-2334-11-86. View

Nachega J, Hislop M, Dowdy D, Lo M, Omer S, Regensberg L . Adherence to highly active antiretroviral therapy assessed by pharmacy claims predicts survival in HIV-infected South African adults. J Acquir Immune Defic Syndr. 2006; 43(1):78-84. DOI: 10.1097/01.qai.0000225015.43266.46. View

Lee S, Lee S, Lee S, Kim K, Lee J, Cho H . Predictors of Poor Retention in Care of HIV-infected Patients Receiving Antiretroviral Therapy in Korea: Five-Year Hospital-based Retrospective Cohort Study. J Korean Med Sci. 2016; 31(3):376-81. PMC: 4779861. DOI: 10.3346/jkms.2016.31.3.376. View

Bing E, Burnam M, Longshore D, Fleishman J, Sherbourne C, London A . Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry. 2001; 58(8):721-8. DOI: 10.1001/archpsyc.58.8.721. View

Orrell C, Bangsberg D, Badri M, Wood R . Adherence is not a barrier to successful antiretroviral therapy in South Africa. AIDS. 2003; 17(9):1369-75. DOI: 10.1097/00002030-200306130-00011. View

Bangsberg D, Ragland K, Monk A, Deeks S . A single tablet regimen is associated with higher adherence and viral suppression than multiple tablet regimens in HIV+ homeless and marginally housed people. AIDS. 2010; 24(18):2835-40. PMC: 3540404. DOI: 10.1097/QAD.0b013e328340a209. View

Granich R, Gupta S, Hall I, Aberle-Grasse J, Hader S, Mermin J . Status and methodology of publicly available national HIV care continua and 90-90-90 targets: A systematic review. PLoS Med. 2017; 14(4):e1002253. PMC: 5380306. DOI: 10.1371/journal.pmed.1002253. View

10.

Zhang S, Rust G, Cardarelli K, Felizzola J, Fransua M, Stringer Jr H . Adherence to highly active antiretroviral therapy impact on clinical and economic outcomes for Medicaid enrollees with human immunodeficiency virus and hepatitis C coinfection. AIDS Care. 2015; 27(7):829-35. PMC: 4888046. DOI: 10.1080/09540121.2015.1021745. View

11.

Bonolo P, Ceccato M, Rocha G, de Assis Acurcio F, Campos L, Crosland Guimaraes M . Gender differences in non-adherence among Brazilian patients initiating antiretroviral therapy. Clinics (Sao Paulo). 2013; 68(5):612-20. PMC: 3654293. DOI: 10.6061/clinics/2013(05)06. View

12.

Hogg R, Heath K, Bangsberg D, Yip B, Press N, OShaughnessy M . Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up. AIDS. 2002; 16(7):1051-8. DOI: 10.1097/00002030-200205030-00012. View

13.

Horberg M, Silverberg M, Hurley L, Towner W, Klein D, Bersoff-Matcha S . Effects of depression and selective serotonin reuptake inhibitor use on adherence to highly active antiretroviral therapy and on clinical outcomes in HIV-infected patients. J Acquir Immune Defic Syndr. 2007; 47(3):384-90. DOI: 10.1097/QAI.0b013e318160d53e. View

14.

Mills E, Nachega J, Buchan I, Orbinski J, Attaran A, Singh S . Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA. 2006; 296(6):679-90. DOI: 10.1001/jama.296.6.679. View

15.

Yang H, Bang J, Kim J, Lee Y, Park Y, Huh I . Factors associated with intention to be tested for HIV among men who have sex with men in a country with a very low HIV prevalence. AIDS Care. 2017; 30(3):289-295. DOI: 10.1080/09540121.2017.1371666. View

16.

Roeloffs C, Sherbourne C, Unutzer J, Fink A, Tang L, Wells K . Stigma and depression among primary care patients. Gen Hosp Psychiatry. 2003; 25(5):311-5. DOI: 10.1016/s0163-8343(03)00066-5. View

17.

Turner B . Adherence to antiretroviral therapy by human immunodeficiency virus-infected patients. J Infect Dis. 2002; 185 Suppl 2:S143-51. DOI: 10.1086/340197. View

18.

Ortego C, Huedo-Medina T, Llorca J, Sevilla L, Santos P, Rodriguez E . Adherence to highly active antiretroviral therapy (HAART): a meta-analysis. AIDS Behav. 2011; 15(7):1381-96. DOI: 10.1007/s10461-011-9942-x. View

19.

Bangsberg D, Perry S, Charlebois E, Clark R, Roberston M, Zolopa A . Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS. 2001; 15(9):1181-3. DOI: 10.1097/00002030-200106150-00015. View

20.

Moatti J, Carrieri M, Spire B, Gastaut J, Cassuto J, Moreau J . Adherence to HAART in French HIV-infected injecting drug users: the contribution of buprenorphine drug maintenance treatment. The Manif 2000 study group. AIDS. 2000; 14(2):151-5. DOI: 10.1097/00002030-200001280-00010. View